Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2008 Sep 12;26 Suppl 4(Suppl 4):D5-9.
doi: 10.1016/j.vaccine.2008.05.076.

Seasonal inactivated influenza virus vaccines

Robert B Couch  1
Affiliations
Review

Seasonal inactivated influenza virus vaccines

Robert B Couch. Vaccine. .

Abstract

Inactivated influenza virus vaccines are the primary modality used for prevention of influenza. A system of annual identification of new strains causing illnesses, selections for vaccines, chick embryo growth, inactivation, processing, packaging, distribution and usage has been in place for decades. Current vaccines contain 15 microg of the HA of an A/H1N1, A/H3N2 and B strain and are given parenterally to induce serum anti-HA antibody for prevention of subsequent infection and illness from natural influenza. Reactogenicity is low and protection among healthy older children and adults is good; protection levels are generally lower in young children and the elderly. Needs include ensuring antigenic matches of vaccine and epidemic viruses each season, enhancing immunization rates, and providing new and improved vaccines and immunization approaches for the varied populations and circumstances globally.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Sequence of Annual Events for Inactivated Influenza Virus Vaccines
See this image and copyright information in PMC

References

    1. Centers for Disease Control and Prevention. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices. MMWR. 2007;56(RR06):1–54. - PubMed
    1. Centers for Disease Control and Prevention. Estimates of influenza vaccination target population sizes in 2006 and recent vaccine uptake levels. 2006. Jul 17, http://www.cdc.gov/flu/professionals/vaccination/pdf/targetpopchart.pdf.
    1. Committee for Proprietary Medicinal Products (CPMP) Notes for guidance on harmonization of requirements for influenza vaccines (CPMP/BWP/214/96)
    1. Couch RB. An Overview of Serum Antibody Responses to Influenza Virus Antigens. In: Brown F, Haaheim LR, Wood JM, Schild GC, editors. Developments in Biologicals: Laboratory Correlates of Immunity to Influenza. Vol. 115. Karger: 2003. pp. 25–30. - PubMed
    1. McElhaney JE, Xie D, Hager WD, Barry MB, Wang Y, Kleppinger A, Ewen C, Kane KP, Bleackley RC. T cell responses are better correlates of vaccine protection in the elderly. J Immunol. 2006;176:6333–6339. - PubMed

Publication types